Pfizer says its antiviral pill slashes risk of severe COVID-19 by 89%
WorldTags: Print EditionCOVID-19coronavirusUS: A trial of Pfizer Inc's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of…
